Swiss Cancer Institute/Novartis Together for Patients Award

Eligible projects are those that aim to prevent or alleviate or reduce the burden of breast cancer and chronic myeloid leukemia (CML) for patients and/or their relatives, thereby significantly improving patient care by optimizing aspects in e.g. in prevention, networking, communication, outcome, quality of life.  

Possible project proposals could include, but are not limited to: 

• Tools to collect Patient-Reported Outcomes to improve patient care 
• (Digital) tools to enhance and support patient self-care (nutrition, movement, psychological and social aspects, etc.) 
• Platforms / projects to facilitate (timely and efficient) patient – physician communication and interaction (virtual visits, remote monitoring)  
• Platforms to facilitate data management / data collection  
• Projects for disease prevention for patients with Breast Cancer and Chronic Myeloid Leukemia (CML) 

The application must:

• be written in English
• contain the following information: Project title, rationale, aim of the project and how the project improves care of breast cancer and/or chronic myeloid leukemia (CML) patients
• a detailed description of the project including project plan, timeframe/duration of the project (max. 5 pages excl. CV)
• a detailed financial plan / budget (please note that the awarded amount is depending on the costs still occurring and may be less than CHF 30,000 if upcoming project costs are smaller. Costs already incurred will not be reimbursed as part of the prize money).
• CV of the applicant(s) (max. 2 pages)

Applications that do not meet all of the above requirements cannot be considered.

Please submit your application by April 27, 2026.

Applications must be submitted electronically to the Swiss Cancer Institute, events@swisscancerinstitute.ch .

In collaboration with Novartis